Cue Biopharma, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CUE Company Description
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
CUE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CUE Smart Score
Score Breakdown
CUE Company Description
Show More
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CUE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CUE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CUE's company Twitter account
WallStreetBets
Number of mentions of CUE in WallStreetBets Daily Discussion
CUE News
Recent insights relating to CUE
CNBC Recommendations
Recent picks made for CUE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CUE
Corporate Flights
Flights by private jets registered to CUE
Our Analysis